Bruker Announces SciY™ Platform of Advanced Scientific and Automation Software Solutions for the Digital Transformation of the Life Science and Biopharma Industries
ZUERICH, Switzerland – June 30, 2023: Bruker Corporation (Nasdaq: BRKR) today announced the SciY™ platform of advanced, vendor-agnostic software solutions for data analysis, data management, research lab and bioproduction QC digitalization, and workflow automation in the life science industry and for biopharma companies.
Bruker Announces Acquisition of ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions
BILLERICA, Massachusetts – May 8, 2023: Bruker Corporation (Nasdaq: BRKR) today announced that is has closed the acquisition of ZONTAL Inc. (www.zontal.io), an innovative platform provider for the digital transformation of the analytical laboratory, and for integrated biopharma technical data solutions.
November 27-28, 2023, Novartis Campus Basel, Switzerland
The Automated Synthesis Forum, an annual non-profit conference, gathers scientists from industry and academia to discuss cutting-edge technologies in synthetic chemistry, both pre- and post-commercialization, for real-world research advancements.